Pulmonary Hypertension in Dogs: Causes, Symptoms & Treatment
Complete guide to understanding, diagnosing, and treating pulmonary hypertension in dogs.

Understanding Pulmonary Hypertension in Dogs
Pulmonary hypertension (PH) is a serious cardiovascular condition that affects dogs of all ages and breeds, though it is more commonly observed in middle-aged to older small-breed dogs. This condition is characterized by abnormally elevated blood pressure in the arteries of the lungs, which can lead to significant complications if left untreated. The condition often develops as a secondary consequence of other underlying diseases, making early detection and comprehensive management essential for improving your dog’s quality of life and prognosis.
Understanding pulmonary hypertension requires knowledge of how the condition develops, what causes it, and how it affects your dog’s overall health. Many dog owners are unaware that their pets have this condition until clinical signs become apparent. By learning about this disease, you can work more effectively with your veterinarian to provide the best possible care for your canine companion.
What is Pulmonary Hypertension?
Pulmonary hypertension is defined as an abnormally increased pressure within the pulmonary vasculature—the network of blood vessels that supply the lungs. In a healthy dog, blood flows from the right side of the heart through the pulmonary arteries to the lungs, where it picks up oxygen before returning to the left side of the heart for distribution throughout the body. When pulmonary hypertension develops, the resistance in these blood vessels increases, forcing the right ventricle to work harder to pump blood through the lungs.
This increased workload can eventually lead to right ventricular dysfunction and heart failure if not properly managed. The condition is often secondary to other diseases rather than a primary disorder, meaning it develops as a result of an underlying health problem. Understanding the underlying cause is crucial for determining the most appropriate treatment strategy for your dog.
Causes of Pulmonary Hypertension in Dogs
Pulmonary hypertension in dogs can develop from various underlying conditions. The most common causes include:
Cardiac Causes
Degenerative mitral valve disease is one of the most frequent causes of pulmonary hypertension in dogs. This condition causes the mitral valve to deteriorate over time, leading to increased pressure in the left atrium and subsequent pulmonary venous hypertension. Left-sided heart failure, mitral valve dysplasia, and other cardiac abnormalities can also contribute to the development of pulmonary hypertension.
Respiratory Diseases
Chronic respiratory conditions such as interstitial lung disease, chronic obstructive pulmonary disease, and other pulmonary parenchymal diseases can cause or contribute to pulmonary hypertension. Severe tracheal collapse and brachycephalic obstructive airway syndrome in flat-faced breeds can also elevate pulmonary pressures over time.
Parasitic Infections
Heartworm disease and other parasitic infections can directly damage pulmonary vessels and increase pulmonary vascular resistance. Even after successful treatment of the parasitic infection, pulmonary hypertension may persist due to permanent vascular remodeling.
Thromboembolic Disease
Blood clots in the pulmonary arteries can obstruct blood flow and significantly increase pulmonary artery pressure. Dogs with thrombotic disease require specific anticoagulant therapy in addition to other treatments.
Neoplasia
Tumors that compress pulmonary vessels or invade the lungs can cause pulmonary hypertension. These cases may require surgical intervention, radiation therapy, or chemotherapy depending on the type and location of the neoplasm.
Clinical Signs and Symptoms
Dogs with pulmonary hypertension typically present with various clinical signs that result from the elevated pressure in the pulmonary arteries and reduced oxygen transport throughout the body. Recognizing these symptoms early can help facilitate prompt veterinary intervention.
The most common clinical signs include:
– Exercise intolerance and reluctance to engage in physical activity- Difficulty breathing with or without exertion (dyspnea)- Rapid or labored breathing at rest- Chronic cough that may be productive- Spitting up blood from the lungs (hemoptysis)- Fainting or syncope episodes- Unexplained weight loss- Heart murmur detected during physical examination- Blue discoloration of the skin and mucous membranes (cyanosis) indicating low blood oxygen levels- Distended jugular veins in the neck- Sudden death in severe cases
These clinical signs occur due to several mechanisms: pulmonary hypertension-induced impaired oxygen transport, reduced cardiac output, and systemic hypotension resulting from systemic vasodilation and underfilling of the right and left ventricles. Some signs may also occur as a direct result of the underlying cause of pulmonary hypertension rather than from the elevated pressures alone.
Diagnosis of Pulmonary Hypertension
Diagnosing pulmonary hypertension requires a comprehensive approach that includes detailed history taking, physical examination, and diagnostic imaging. Most dogs with pulmonary hypertension are small-breed and middle-aged to older, which coincides with the high prevalence of pulmonary hypertension in patients with degenerative mitral valve disease.
Physical Examination and Signalment
During the physical examination, your veterinarian will assess your dog’s overall condition and listen carefully for heart and lung abnormalities. They will note breed, age, and body condition, as well as obtain a detailed history regarding the onset and progression of clinical signs. Exercise intolerance, cough, dyspnea, and syncope are the most commonly reported complaints from owners of dogs with pulmonary hypertension.
Echocardiography
Echocardiography is the primary diagnostic tool for identifying pulmonary hypertension. This ultrasound examination of the heart allows the veterinarian to estimate pulmonary artery pressure by measuring tricuspid regurgitation velocity (TRV). Echocardiography also helps identify structural cardiac abnormalities and assess right ventricular function, which are crucial for determining the underlying cause of pulmonary hypertension.
Additional Diagnostic Imaging
Chest radiographs may reveal enlarged pulmonary arteries, lung disease, or other abnormalities contributing to pulmonary hypertension. Additional imaging such as CT scans or advanced ultrasonography may be warranted in some cases to identify underlying causes like thromboembolic disease or pulmonary neoplasia.
Laboratory Tests
Blood work and other laboratory tests help identify underlying conditions such as heartworm disease or other systemic abnormalities that might contribute to pulmonary hypertension development.
Treatment Options for Pulmonary Hypertension
Treatment of pulmonary hypertension should focus on multiple goals: decreasing clinical signs, improving exercise tolerance, reducing dyspnea and cough, decreasing syncopal events, reducing hospitalization time, improving quality of life, and increasing survival time. The primary approach involves identifying and treating the underlying cause of pulmonary hypertension, combined with medications to decrease pulmonary arterial pressure and reduce the workload of the right ventricle.
Sildenafil (Viagra®)
Sildenafil is a short-acting phosphodiesterase type 5 (PDE5) inhibitor and is considered the drug of choice for treating pulmonary hypertension in dogs. The recommended dosage is 1 to 3 mg/kg administered by mouth every 8 to 12 hours. Sildenafil has been evaluated in clinical settings and has been shown to decrease pulmonary arterial pressure, improve quality of life, and improve survival time. It typically has minimal gastrointestinal side effects and, while relatively expensive, may be affordable for many clients. Sildenafil is particularly warranted in dogs with clinical signs due to pulmonary hypertension, most commonly syncope and right heart failure.
Tadalafil (Cialis®)
Tadalafil is another PDE5 inhibitor with a longer half-life than sildenafil, allowing for less frequent dosing. The typical dose is approximately 1 mg/kg administered by mouth every 12 to 24 hours. While there is limited clinical experience with tadalafil in dogs, in theory it should have similar effects to sildenafil in lowering pulmonary artery pressure.
Pimobendan (Vetmedin®)
Pimobendan is an inodilator that decreases pulmonary artery pressure in dogs with pulmonary hypertension secondary to left heart failure. This medication is particularly useful for dogs whose pulmonary hypertension results from mitral valve disease or other left-sided cardiac conditions. When left-sided heart disease is the cause, pimobendan should be considered before starting sildenafil therapy. However, sildenafil can precipitate congestive heart failure in patients with pulmonary hypertension caused by left-sided heart disease and should be used with caution in these patients.
Imatinib (Glivec®)
Imatinib has been used in select cases of pulmonary hypertension in dogs, though its role in clinical practice is less established compared to sildenafil and other more commonly used medications.
Endothelin Antagonists
Bosentan, an endothelin antagonist, has been assessed in dogs in experimental settings and has been found to decrease vascular remodeling in induced pulmonary hypertension, improve myocardial function, and decrease ventricular remodeling. Unfortunately, there are no clinical trials of endothelin antagonists in dogs with naturally occurring disease. While less expensive than prostacyclin analogues, endothelin antagonists are still considered cost-prohibitive in veterinary patients.
Supportive Care and Environmental Management
In addition to medications, supportive care plays a crucial role in managing pulmonary hypertension. Once your dog is home from treatment, it is important to maintain a low-stress environment while any underlying cardiac or respiratory disease is treated and managed. Activity restriction may be necessary depending on the severity of the condition and your dog’s clinical signs.
Environmental Modifications
Avoid environments that may increase the likelihood of breathing distress, including:
– Excessively cold or dry air- Excessive heat- Second-hand smoke exposure- High altitudes- Stressful situations
Oxygen Therapy
Pets with advanced pulmonary hypertension may benefit from oxygen therapy, and may even need to be hospitalized with oxygen to manage acute breathing crises. Oxygen therapy is very helpful for dogs with pulmonary hypertension who are in the hospital because they are having significant trouble breathing. For severe breathing distress, treatment includes hospitalization with oxygen therapy and medication to dilate the breathing passages. If needed, your dog may be given medication to remove excess fluid from the lungs. Portable oxygen canisters are available for home use, though if your pet is having enough trouble breathing to require oxygen, this should generally be considered a temporary measure and they should be brought to the hospital.
Treatment of Underlying Conditions
Patients with pulmonary hypertension often require specific therapies based on the underlying cause:
– Treatment of pulmonary disease with anti-inflammatory or bronchodilating agents- Treatment of congestive heart failure with diuretics- Treatment of neoplasia with appropriate chemotherapy- Treatment of thromboembolic disease with anticoagulant medications and corticosteroids- Heartworm adulticide therapy for dogs with heartworm disease- Tracheal stent placement for severe tracheal collapse- Surgical correction of obstructive anatomy leading to brachycephalic obstructive airway syndrome
Prognosis and Long-Term Outlook
The prognosis for dogs with pulmonary hypertension varies depending on the severity of the condition and the underlying cause. Successfully reducing the severity of pulmonary hypertension will improve a dog’s quality of life. However, pulmonary hypertension tends to be a progressive condition that often becomes resistant to treatment over time. This is why it is so important to establish a diagnosis early while your dog has the best chance for responding to treatment.
Some dogs with pulmonary hypertension live well for months or even years with appropriate treatment, while others decline more rapidly depending on the severity and underlying causes. By the time pulmonary hypertension is diagnosed, the underlying condition has often persisted for so long that the lung changes are irreversible, making the condition difficult to completely resolve.
Identifying and treating the underlying disease offers the best chance for a successful long-term outcome; however, such identification and treatment are rare once irreversible vascular changes have occurred.
Monitoring and Follow-Up Care
Dogs with pulmonary hypertension require regular monitoring to assess response to treatment and detect progression or complications. Your veterinarian will likely recommend periodic echocardiograms to reassess pulmonary artery pressures and right ventricular function. Additionally, monitoring your dog’s resting respiratory rate and clinical signs at home allows for prompt intervention with treatment adjustments if needed, particularly to address congestive heart failure if it develops during treatment with sildenafil.
Frequently Asked Questions
Q: What is the most common cause of pulmonary hypertension in dogs?
A: Degenerative mitral valve disease is one of the most common causes of pulmonary hypertension in dogs, particularly in older small-breed dogs. Other frequent causes include chronic respiratory diseases, heartworm disease, and left-sided heart failure.
Q: Can pulmonary hypertension be cured in dogs?
A: While the underlying cause may sometimes be treated successfully, by the time pulmonary hypertension is diagnosed, permanent vascular changes have usually occurred, making complete reversal of the condition difficult. Treatment focuses on managing symptoms and slowing progression.
Q: Is sildenafil safe for all dogs with pulmonary hypertension?
A: Sildenafil is generally safe and considered the drug of choice for pulmonary hypertension in dogs. However, it should be used with caution in dogs with pulmonary hypertension caused by left-sided heart disease, as it can precipitate congestive heart failure in these cases.
Q: How often will my dog need veterinary check-ups if diagnosed with pulmonary hypertension?
A: Frequency of check-ups depends on your dog’s condition and response to treatment. Your veterinarian will recommend a monitoring schedule that typically includes periodic echocardiograms and physical examinations to assess treatment effectiveness and detect complications.
Q: Can exercise be beneficial for dogs with pulmonary hypertension?
A: Most dogs with pulmonary hypertension experience exercise intolerance, so activity restriction is typically recommended. Your veterinarian will advise on appropriate activity levels based on your dog’s specific condition and clinical signs.
Q: What should I do if my dog shows signs of difficulty breathing?
A: If your dog shows acute signs of breathing distress, seek immediate veterinary care. This may require emergency hospitalization with oxygen therapy and medication to support heart and lung function.
References
- Canine Pulmonary Hypertension, Part 2: Diagnosis and Treatment — DVM360. 2024. https://www.dvm360.com/view/canine-pulmonary-hypertension-part-2-diagnosis-and-treatment
- Systemic and Pulmonary Hypertension in Dogs and Cats — Merck Veterinary Manual. 2024. https://www.merckvetmanual.com/circulatory-system/various-cardiovascular-diseases-in-dogs-and-cats/systemic-and-pulmonary-hypertension-in-dogs-and-cats
- Pulmonary Hypertension in Dogs — Today’s Veterinary Practice. 2024. https://todaysveterinarypractice.com/cardiology/pulmonary-hypertension-in-dogs/
- Pulmonary Hypertension in Dogs — VCA Animal Hospitals. 2024. https://vcahospitals.com/know-your-pet/pulmonary-hypertension-in-dogs
- ACVIM Consensus Statement Guidelines for the Diagnosis, Classification, Treatment, and Monitoring of Pulmonary Hypertension in Dogs — National Institutes of Health. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7097566/
- Pulmonary Hypertension — MU Veterinary Health Center. 2024. https://vhc.missouri.edu/small-animal-hospital/small-animal-internal-medicine/diseases-and-treatments/pulmonary-hypertension/
Read full bio of Sneha Tete










